Lima Memorial Health System Logo
Approximate ER WAIT TIME WAIT TIME MACRO

Health Library

Ewing sarcoma
     
Print-Friendly
Bookmarks

Ewing sarcoma

Bone cancer - Ewing sarcoma; Ewing family of tumors; Primitive neuroectodermal tumors (PNET); Bone neoplasm - Ewing sarcoma; Ewing's sarcoma

 

Ewing sarcoma is a malignant bone tumor that forms in the bone or soft tissue around it. It affects mostly teens and young adults.

Causes

 

Ewing sarcoma can occur anytime during childhood and young adulthood. But it usually develops during puberty, when bones are growing rapidly. It is more common in White children than in Black or Asian children.

The tumor may start anywhere in the body. Most often, it starts in the long bones of the arms and legs, the pelvis, or the chest. It can also develop in the skull or the flat bones of the trunk.

The tumor often spreads (metastasizes) to the lungs and other bones. At the time of diagnosis, spread is seen in about 25% of children with Ewing sarcoma.

In rare cases, Ewing sarcoma occurs in adults.

 

Symptoms

 

There are few symptoms. The most common is pain and sometimes swelling at the site of the tumor.

Because the tumor weakens the bone, children may also break a bone at the site of the tumor after a minor injury.

Fever may also be present.

 

Exams and Tests

 

If a tumor is suspected, tests to locate the primary tumor and any spread (metastasis) often include:

  • Bone scan
  • Chest x-ray
  • CT scan of the chest
  • MRI of the tumor
  • X-ray of the tumor

A biopsy of the tumor will be done. Different tests are done on this tissue to help determine how aggressive the cancer is and what treatment may be best.

 

Treatment

 

Treatment often includes a combination of:

  • Chemotherapy
  • Radiation therapy
  • Surgery to remove the primary tumor

Treatment depends on the following:

  • Stage of the cancer
  • Age and sex of the person
  • Results of the tests on the biopsy sample

 

Support Groups

 

The stress of illness can be eased by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.

 

Outlook (Prognosis)

 

Before treatment, the outlook depends on:

  • Whether the tumor has spread to distant parts of the body
  • Where in the body the tumor started
  • How large the tumor is when it's diagnosed
  • Whether the lactate dehydrogenase (LDH) level in the blood is higher than normal
  • Whether the tumor has certain gene changes
  • Whether the child is younger than 15 years
  • Child's sex
  • Whether the child has had treatment for a different cancer before Ewing sarcoma
  • Whether the tumor has just been diagnosed or has come back

The best chance for cure is with a combination of treatments that includes chemotherapy plus radiation or surgery.

 

Possible Complications

 

The treatments needed to fight this disease may have many complications. Discuss these with your health care provider.

 

When to Contact a Medical Professional

 

Contact your provider if your child has any of the symptoms of Ewing sarcoma. An early diagnosis can increase the possibility of a favorable outcome.

 

 

References

Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Pediatric solid tumors. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 92.

Kliegman RM, St. Geme JW, Blum NJ, et al. Neoplasms of bone. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 550.

National Cancer Institute website. Ewing sarcoma and undifferentiated small round cell sarcomas of bone and soft tissue treatment (PDQ) - health professional version. www.cancer.gov/types/bone/hp/ewing-treatment-pdq. Updated November 27, 2024. Accessed April 9, 2026.

National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology (NCCN guidelines): Bone cancer. Version 2.2026. www.nccn.org/professionals/physician_gls/pdf/bone.pdf. Updated December 19, 2025. Accessed April 9, 2026.

BACK TO TOPText only

 
  • X-ray

    X-ray

    illustration

  • Ewing sarcoma - X-ray

    Ewing sarcoma - X-ray

    illustration

    • X-ray

      X-ray

      illustration

    • Ewing sarcoma - X-ray

      Ewing sarcoma - X-ray

      illustration

    Tests for Ewing sarcoma

     
       

      Review Date: 1/29/2026

      Reviewed By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

      The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

      © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

      All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.
      © 1997- adam.comAll rights reserved.